272 related articles for article (PubMed ID: 10809812)
1. A clinicopathological study of IgA nephropathy in renal transplant recipients: beneficial effect of angiotensin-converting enzyme inhibitor.
Oka K; Imai E; Moriyama T; Akagi Y; Ando A; Hori M; Okuyama A; Toki K; Kyo M; Kokado Y; Takahara S
Nephrol Dial Transplant; 2000 May; 15(5):689-95. PubMed ID: 10809812
[TBL] [Abstract][Full Text] [Related]
2. Segmental glomerulosclerosis in IgA nephropathy after renal transplantation: relationship with proteinuria and therapeutic response to enalapril.
Jeong HJ; Kim YS; Kwon KW; Kim MS; Kim S; Choi KH; Lee HY; Han DS; Park K
Clin Transplant; 2003 Apr; 17(2):108-13. PubMed ID: 12709075
[TBL] [Abstract][Full Text] [Related]
3. [The effects of angiotensin-converting enzyme inhibitor on IgA nephropathy and the influencing factors].
Shi X; Chen X; Liu S; Zhuang Y; Zhang Y
Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):399-403. PubMed ID: 12137603
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for graft loss in patients with recurrent IGA nephropathy after renal transplantation.
Namba Y; Oka K; Moriyama T; Ichimaru N; Kyo M; Kokado Y; Ito T; Imai E; Aozasa K; Okuyama A; Takahara S
Transplant Proc; 2004 Jun; 36(5):1314-6. PubMed ID: 15251321
[TBL] [Abstract][Full Text] [Related]
5. Utility of Oxford Classification in Post-Transplant Immunoglobulin A Nephropathy.
Agrawal V; Singh A; Kaul A; Verma R; Jain M; Pandey R
Transplant Proc; 2017 Dec; 49(10):2274-2279. PubMed ID: 29198660
[TBL] [Abstract][Full Text] [Related]
6. Glomerular C4d in Post-Transplant IgA Nephropathy is associated with decreased allograft survival.
Eder M; Kozakowski N; Omic H; Aigner C; Kläger J; Perschl B; Reindl-Schwaighofer R; Bond G; Böhmig GA; Kikić Ž
J Nephrol; 2021 Jun; 34(3):839-849. PubMed ID: 33306182
[TBL] [Abstract][Full Text] [Related]
7. Glomerular crescents are associated with worse graft outcome in allograft IgA nephropathy.
Park S; Baek CH; Cho H; Yu MY; Kim YC; Go H; Kim YH; Lee JP; Min SI; Ha J; Moon KC; Kim YS; Ahn C; Park SK; Lee H
Am J Transplant; 2019 Jan; 19(1):145-155. PubMed ID: 29718591
[TBL] [Abstract][Full Text] [Related]
8. IgA NEPHROPATHY IN PATIENTS RECEIVING A RENAL TRANSPLANT.
Lemes-Canuto AP; de Sandes-Freitas TV; Medina-Pestana JO; Mastroianni-Kirsztajn G
J Ren Care; 2015 Dec; 41(4):222-30. PubMed ID: 25819382
[TBL] [Abstract][Full Text] [Related]
9. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study.
Wu H; Xia Z; Gao C; Zhang P; Yang X; Wang R; Wang M; Peng Y
BMC Nephrol; 2020 Jul; 21(1):247. PubMed ID: 32611399
[TBL] [Abstract][Full Text] [Related]
10. Predicting Post-Transplant Recurrence of IgA Nephropathy: The Importance of Crescents.
Avasare RS; Rosenstiel PE; Zaky ZS; Tsapepas DS; Appel GB; Markowitz GS; Bomback AS; Canetta PA
Am J Nephrol; 2017; 45(2):99-106. PubMed ID: 28056461
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting-enzyme inhibitors slow renal decline in IgA nephropathy, independent of tubulointerstitial fibrosis at presentation.
Kanno Y; Okada H; Yamaji Y; Nakazato Y; Suzuki H
QJM; 2005 Mar; 98(3):199-203. PubMed ID: 15728401
[TBL] [Abstract][Full Text] [Related]
12. Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection.
Riispere Ž; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
BMC Nephrol; 2017 Mar; 18(1):89. PubMed ID: 28292274
[TBL] [Abstract][Full Text] [Related]
13. Recurrence of crescentic IgA nephropathy after renal transplantation.
Zagkotsis G; Vourlakou C; Paraskevopoulos A; Apostolou T
CEN Case Rep; 2018 Nov; 7(2):268-273. PubMed ID: 29802527
[TBL] [Abstract][Full Text] [Related]
14. The beneficial effects of renin-angiotensin system inhibitors (RASI) on IgA nephropathy with tubulointerstitial lesions categorized by Oxford classification.
Kamiyama T; Moriyama T; Kumon S; Karasawa K; Nitta K
Clin Exp Nephrol; 2019 Jun; 23(6):834-840. PubMed ID: 30796546
[TBL] [Abstract][Full Text] [Related]
15. Tonsillectomy and steroid pulse therapy for recurrent IgA nephropathy in renal allograft.
Tsuchiya T; Ito S; Yamaguchi Y; Moriyama Y; Ehara H; Deguchi T
Clin Nephrol; 2010 Jan; 73(1):68-71. PubMed ID: 20040355
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of IgA Nephropathy with Segmental Glomerular Necrosis But without Crescent Formation.
Tan M; Li W; Zou G; Zhang C; Fang J
Am J Nephrol; 2016; 43(5):341-7. PubMed ID: 27166147
[TBL] [Abstract][Full Text] [Related]
17. [A clinicopathological study of recurrent IgA nephropathy following renal transplantation].
Matsugami K; Naito T; Nitta K; Nihei H; Tanabe K; Toma H; Yamaguchi Y
Nihon Jinzo Gakkai Shi; 1998 Jul; 40(5):322-8. PubMed ID: 9752688
[TBL] [Abstract][Full Text] [Related]
18. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
Bazzi C; Rizza V; Casellato D; Stivali G; Rachele G; Napodano P; Olivieri G; Gallieni M; D'Amico G
J Nephrol; 2012; 25(5):810-8. PubMed ID: 22252844
[TBL] [Abstract][Full Text] [Related]
19. Progression of renal allograft histology after renal transplantation in recurrent and nonrecurrent immunoglobulin A nephropathy.
Jeong HJ; Park SK; Cho YM; Kim MS; Kim YS; Choi J; Kim SI; Lim BJ
Hum Pathol; 2008 Oct; 39(10):1511-8. PubMed ID: 18620732
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
Manno C; Torres DD; Rossini M; Pesce F; Schena FP
Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
